Ignite Creation Date:
2024-05-06 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06022003
Status:
RECRUITING
Last Update Posted:
2024-02-06
First Post:
2023-08-28
Brief Title:
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects 18 Years of Age With RelapsedRefractory FLT3-mutated Acute Myeloid Leukemia
Sponsor:
French Innovative Leukemia Organisation
Organization:
French Innovative Leukemia Organisation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| AML Adult |
| Refractory AML |
| Relapsed Adult AML |
| FLT3-TKD Mutation |
| FLT3-ITD |
Keywords: